Akums Drugs and Pharmaceuticals Limited (NSE:AKUMS)
460.55
-2.50 (-0.54%)
At close: Oct 24, 2025
NSE:AKUMS Revenue
Akums Drugs and Pharmaceuticals had revenue of 10.24B INR in the quarter ending June 30, 2025, with 0.48% growth. This brings the company's revenue in the last twelve months to 41.26B, down -2.48% year-over-year. In the fiscal year ending March 31, 2025, Akums Drugs and Pharmaceuticals had annual revenue of 41.21B, down -1.45%.
Revenue (ttm)
41.26B
Revenue Growth
-2.48%
P/S Ratio
1.71
Revenue / Employee
5.48M
Employees
7,536
Market Cap
70.51B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 41.21B | -605.31M | -1.45% |
| Mar 31, 2024 | 41.82B | 5.24B | 14.34% |
| Mar 31, 2023 | 36.57B | -180.32M | -0.49% |
| Mar 31, 2022 | 36.75B | 9.49B | 34.81% |
| Mar 31, 2021 | 27.26B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 537.77B |
| Aurobindo Pharma | 320.25B |
| Cipla | 274.80B |
| Zydus Lifesciences | 236.08B |
| Apollo Hospitals Enterprise | 225.51B |
| Glenmark Pharmaceuticals | 134.56B |
| Alkem Laboratories | 133.04B |
| Mankind Pharma | 129.10B |
Akums Drugs and Pharmaceuticals News
- 6 days ago - Akums Drugs incorporates wholly owned subsidiary in Malta, Europe - Business Upturn
- 3 months ago - SIMMONS FIRST NATIONAL CORPORATION ANNOUNCES PRICING OF OFFERING OF COMMON STOCK - Benzinga
- 9 months ago - Akums Drugs and Pharmaceuticals shares fall over 6% following Income Tax Department search - Business Upturn
- 10 months ago - Akums Drugs secures Rs 1,760 deal to supply oral liquid formulations in Europe - Business Upturn
- 11 months ago - Akums Drugs partners with Jagdale to revolutionize India’s Ready-to-Drink nutritional beverage market - Business Upturn
- 1 year ago - Akums Drugs shares surge 5% after signing Master Sales Agreement with Caregen - Business Upturn
- 1 year ago - Akums Drugs signs Master Sales Agreement with Caregen for Indian Nutraceutical market expansion - Business Upturn
- 1 year ago - Akums Drugs and Pharmaceuticals shares fall 5% following weak Q2 earnings outlook - Business Upturn